Harvard Scientific (HVSF)Hot$$- male impotency medicine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nanda who wrote (2643)	1/14/1998 6:01:00 PM
From: Afaq Sarwar	Read Replies (2) of 3906

Nanda, Thanks. And congratulations to you too as well! Question: Why $4 specifically? Any particular reason (technical indicators, etc. or others) or just gut feeling. I believe that they are both equally valid. My hope is that the stock climbs to around $5 or so before HVSF receives approval from FDA to proceed with Phase II. My sense is that all the preparatory work to start Phase II is in place. Also, if stock price gets to around $4 or $5, may be the company can require the debenture holder to covert. That will be a nice little change. In any case I would to stay for the long haul. It will be nice to see this stock achieve the valuation that VVUS has alraedy achieved (not their current valuation). Afaq Sarwar

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next